Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
rh-Endostatin
DRUG
2 trials
Sponsors
Xinjiang Medical University
, Guangzhou Institute of Respiratory Disease
Conditions
Non-small Cell Lung Cancer
Staging IV NSCLC
Phase 2
Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC
NCT04094909
Guangzhou Institute of Respiratory Disease
Staging IV NSCLC
Start: 2020-02-06
End: 2023-03-31
Target: 186
Updated: 2020-02-07
Phase 3
Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB
NCT02001168
Xinjiang Medical University
Non-small Cell Lung Cancer
Start: 2013-10-31
End: 2022-10-31
Target: 392
Updated: 2013-12-04